CSBR
NASDAQ · Life Sciences Tools & Services
Champions Oncology Inc
$6.16
-0.27 (-4.20%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+378.1% upside
Low Target
$20.89
Average Target
$29.45
High Target
$33.06
Current Price
$6.16
Current
$6.16
$6.16
Target
$29.45
$29.45
$20.89
$29.45 avg
$33.06
Scenario Analysis
Bear Case
$20.89
239.1%
Low target
Base Case
$29.45
+378.1%
Avg target
Bull Case
$33.06
+436.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$9.63
-36.0% from high
52-Week Low
$5.50
+12.0% from low
Target vs 52W High
$29.45
+205.8% vs high
Next Earnings Report
Jul 16, 2026 · After Market Close
14d
until earnings
EPS Est: $-0.05
Earnings in 14 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 85% | $369.21 | -26.4% |
| DHR | Strong Buy | 30 | 90% | $158.11 | -17.0% |
| A | Strong Buy | 28 | 79% | $64.69 | -51.3% |
| WAT | Buy | 28 | 57% | $189.60 | -49.4% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -57.1% |
| ILMN | Buy | 28 | 61% | $169.36 | -3.7% |
| MTD | Hold | 20 | 50% | $170.43 | -86.7% |
| WST | Strong Buy | 22 | 82% | $136.24 | -62.1% |